Revenio Group Corporation Managers’ transactions May 23, 2022 at 9.30 a.m. (EEST)

 Revenio Group Oyj: Managers' Transactions – Ari Isomäki
___________________________________________
Person subject to the notification requirement
Name: Ari Isomäki
Position: Other senior manager
Issuer: Revenio Group Oyj
LEI: 743700I27E0FWSXLKK04
Notification type: INITIAL NOTIFICATION
Reference number: 15343/7/6
___________________________________________
Transaction date: 2022-05-19
Venue: NASDAQ HELSINKI LTD (XHEL)
Instrument type: SHARE
ISIN: FI0009010912
Nature of the transaction: DISPOSAL

Transaction details
(1): Volume: 500 Unit price: 45 EUR
Aggregated transactions
(1): Volume: 500 Volume weighted average price: 45 EUR

For further information, please contact:
CFO Robin Pulkkinen, tel. +358 50 505 9932
robin.pulkkinen@revenio.fi
www.revenio.fi

DISTRIBUTION:
Nasdaq Helsinki Ltd
Main media
www.revenio.fi
Revenio Group in brief

Revenio is a leading company in the global market for ophthalmological devices and software solutions. Revenio’s ophthalmic diagnostic solutions include intraocular pressure (IOP) measurement devices (tonometers), fundus imaging devices, and perimeters as well as clinical software under the iCare brand. iCare is a trusted partner in ophthalmic diagnostics, offering physicians fast, easy-to-use, and reliable tools for the diagnosis of glaucoma, diabetic retinopathy, and macular degeneration (AMD). iCare software solutions provide eye care professionals with new innovative digital clinical tools that drive greater efficiency and enhance the quality of care.

In 2021, the Group’s net sales totaled EUR 78.8 million, with an operating profit of EUR 22.1 million. Revenio Group Corporation is listed on Nasdaq Helsinki with the trading code REG1V.

Attachments

Revenio Group Corporation: Managers' Transactions – Ari Isomäki

© Modular Finance, source Nordic Press Releases